StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:52 UTC

NBIX — Neurocrine Biosciences, Inc.

UNDERVALUED (MOS +51.4%) · Quality 82/100

Price
146.23
Intrinsic value
300.67
Margin of safety
+51.4%
Implied growth (reverse DCF)
+3.1%
model assumes +12.0%
Value Score
56.8
Quality
82
Psychology
21.2
Discovery
29.3
price/volume attention only
Moat score
74.5
erosion: none

Value Score: top 1% of Russell 3000 · Quality: top 9%

Open the interactive Deep Dive for NBIX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NBIX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NBIX undervalued?

As of 2026-09-19, NBIX trades at 146.23 against a computed intrinsic value of 300.67 (+51.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Neurocrine Biosciences, Inc.'s Value Score?

Neurocrine Biosciences, Inc.'s Value Score is 56.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.